BHM® COVID-19 IVD PRODUCTS RECEIVES CE MARKING

Birmingham Biotech has registered the BHM® COVID-19 Antigen Sealing Tube Test Strip, a lateral flow immunochromatographic assay for in vitro qualitative detection of COVID-19 nucleocapsid protein antigen. The test strip is in a sealing tube to avoid potential biosecurity substances from a clinical sample, which will much help to avoid pathogen contamination and spreading to the operator and its environment. 

Birmingham Biotech has registered the BHM® COVID-19 Antigen Rapid Test, a lateral flow immunochromatographic assay for in vitro qualitative detection of COVID-19 nucleocapsid protein antigen. The reagent utilises the principle of double antibody sandwich combines with colloidal gold immunochromatography. 

        

Birmingham Biotech has registered the BHM® SARS-CoV-2-NP Ab Rapid Test. The reagent employs lateral flow immunofluorescent double-antigen sandwich assay in a cassette format with Immunofluorescence Analyser. The product is used for in vitro qualitative detection of anti-SARS-CoV-2-NP antibody (total antibody against SARS-CoV-2 nucleocapsid protein) in human serum.

                                                                                                                                       

Birmingham Biotech has registered the BHM® SARS-CoV-2-S1 Ab Rapid Test. The reagent employs lateral flow immunofluorescent double-antigen sandwich assay in a cassette format with Immunofluorescence Analyser. The product is used for in vitro qualitative detection of anti-SARS-CoV-2-S1 antibody (total antibody against SARS-CoV-2 spike 1 protein) in human serum. 

Birmingham Biotech has registered the BHM® SARS-CoV-2 Ab Detection ELISA Kit. The kit is used for in vitro qualitative detection of antibodies to the COVID-19 N protein in human serum. The kit uses the double antigen sandwich method. The kit contains the gene-expressing novel coronavirus N protein-coated microplate. 

Birmingham Biotech has registered the BHM® SARS-CoV-2-S1 Ab Detection ELISA Kit. The kit is used for in vitro qualitative detection of antibodies to the COVID-19 S protein in human serum. The kit uses the double antigen sandwich method. The kit contains the gene-expressing novel coronavirus S protein-coated microplate.                                                                          

Birmingham Biotech has registered the BHM® 2019-nCoV Nucleic Acid Test Kit (PCR-fluorescent probe method, lyophilized). This kit is a real-time reverse transcription polymerase chain reaction (rRT -PCR) test specially targeting at ORF1ab and N genes of SARS-CoV-2. 

                                                                                                                                        Birmingham Biotech has registered the BHM® Virus Nucleic Acid Extraction Kit or Nucleic Acid Detection Kit. This kit is used to extract virus DNA/RNA from plasma, serum, ascites, cell culture supernatant, cerebrospinal fluid, stool, tissue and other samples. The extracted nucleic acid can be used for clinical molecular biology detection 

Previous
Previous

UNIVERSITY OF BIRMINGHAM TO CONDUCT COVID-19 TEST EVALUATION

Next
Next

EXCLUSIVE DISTRIBUTION OF QUANTUMTEC IN THE UK & INDONESIA